Professor of Endocrinology, Athens University School of Medicine. She has served as an Officer in the Executive Committee of the European Society of Endocrinology and in the Executive Committee of the European Thyroid Association. She serves in the editorial board of several international journals of endocrinology (European Thyroid Journal, Experimental Clinical Endocrinology and Diabetes, Thyroid Research, Hormones). Currently deputy Chief Editor of the European Journal of Endocrinology. She has over 150 publications in peer reviewed medical journals.
Christiani Andrade Amorim
Prof Christiani Amorim is Professor at the Catholic University of Louvain, in Belgium. She has been focusing her attention on cryopreservation and transplantation of ovarian tissue and the development of a transplantable artificial ovary to restore fertility in cancer patients. Her pioneering studies served as basis to start the field of ovarian tissue engineering and she has been actively organizing the first group on reproductive tissue engineering.
Basak Balaban obtained her Bachelor’s degree in 1993 from the University of Ankara,Turkey, working in the faculty of Biological Sciences. Following her clinical embryology training and education at the Ankara Sevgi Hospital-Turkey in between the years 1994-1996, she was certificated for the laboratory based procedural applications of IVF (In-vitro fertilization) at The Schoysman Infertility Manegement Foundation (SIMAF), Brussels, Belgium, and certificated in 1996 by the Health Ministry of Turkey, as a laboratory director for an IVF clinic. She founded and chaired the IVF laboratory in the Assisted Reproduction Unit of German Hospital, Istanbul, Turkey in 1996. She became the chief embryologist in the American Hospital of Istanbul, Turkey Assisted Reproduction Unit at the end of 1996. She is still the principal embryologist in this laboratory that performs over 1200 IVF/ICSI (ICSI-Intracytoplasmic sperm injection) cycles per year. Her major interest areas are embryo selection and in-vitro culture techniques, cryopreservation, and blastocyst culture. She has published and lectured extensively in these fields. She’s a member of ESHRE since 1996, and a board member of CNR (Committee for National Representatives) since 2008. She had been the chair of the Alpha society ; an International Society of Scientists in Reproductive Medicine from 2008 till 2012 for two terms and was a board member since 2015. She had acted as the congress president of the society’s 2008 and 2014 biennal meetings in Istanbul and Antalya, and she remained to be one of the the main organizers of other biennals in Budapest and London. She was also the main organizer of the three consensus meetings, and publications on behalf of the society. She’s a member of the board of directors of ISIVF –International Society for In vitro Fertilization since 2013. She’s one of the founders and the chair of the Turkish Society of Clinical Embryologists (KED) since 2011.
Senior Researcher at Basic Research Lab of Eugin Group in Barcelona (Spain). She has over 20 years of experience in Molecular Biology in Cancer and Stem Cells models and she was involved in reproductive biology since 2013. The Basic Research Lab of Eugin Group is focused on understanding molecular and cellular mechanisms involved in human gamete quality.
graduated in biomedical sciences at the University of Istanbul (Turkey) in 1996. He obtained a master’s degree in biology and medical genetics at the University of Marmara (Turkey). He received a scholarship from the Turkish Council for Scientific and Technological Research (TUBITAK) in 1999. In 2011, he obtained a PhD at the Sapienza University in Rome (Italy) in the Department of Obstetrics and Gynecology. He is currently working at Genom Molecular Genetics Laboratory as a coordinator of preimplantation diagnostics (PGD). His current research interests include the development of new diagnostic strategies and the use of new technologies in preimplantation diagnosis (PGD) of single gene disorders and pre-implantation diagnostics (PGD) and preimplantation screening (PGS) chromosomal aberrations reconciliations and aneuploids.
Research interests of Lars Bjorndahl include: male reproductive physiology – ejaculation and glandular secretion – sperm chromatin structure and DNA protection; basic semen analysis, purification methods, quality control and standardization.
Medical Director of the Centre for Reproductive Medicine, University Hospitals Brussels (UZ Brussel), Belgium. Prof. Blockeel graduated from the University of Ghent, Belgium in 2000 and became a specialist in obstetrics and gynaecology in 2005. In 2008, he was recognised as a subspecialist in reproductive medicine and surgery by ESHRE and the European Board and College of Obstetrics and Gynaecology. He obtained his PhD with a thesis entitled “The optimisation of the follicular phase in GnRH antagonist cycles” in 2012 and became Professor at the Free University of Brussels (VUB), Belgium, the same year. Prof. Blockeel has worked in the field of infertility for several years, with his main interest being reproductive endocrinology. He has published scientific work in many peer-reviewed journals and lectured at many international meetings.
Andrea Borini MD is Clinical and Scientific Director at Tecnobios Procreazione, Centre for Reproductive Health. Bologna, Italy. After completing his MD degree at the University of Bologna in 1986, Dr Borini obtained his specialization degree in Obstetrics and Gynaecology from the same institution in 1991. During this time, he was also a Research Fellow at the University of California Irvine, Irvine, California (1989–1991) and in 2007 he attained a Master’s degree in Andrology at the University of Padova, Padova, Italy. Andrea Borini MD is Chairman of Italian Society of Fertility, Sterility and Reproductive Medicine (SIFES e MR). He has been a past-Chairman of the CECOS – Italy (2002 – 2008) and PROFERT – Italian Society for Fertility Preservation (2008-2013). Andrea Borini MD is member of the editorial board of Fertility and Sterility and associate editor for Reproductive BioMedicine Online and JARG.
Ernesto Bosch graduated in medicine at the University of Valencia in 1992, and from 1993 to 1997 he worked as a specialist in obstetrics and gynecology at the La Fe Hospital in Valencia. He completed an internship in the field of human reproduction at the University of Pennsylvania in 1997. In 1999 he defended his doctoral thesis on the influence of lutropin on the quality of oocytes, with cum laude distinction at the University of Valencia. In January 2000, Ernesto began working at the Department of Human Reproduction at the Institute of Infertility at the University of Valencia. In 2008 he obtained a master’s degree in the field of health sciences research at the Autonomous University of Barcelona. Author of 76 publications. He gave over 150 lectures at international meetings. He belongs to the editorial committee of the magazine “Fertility & Sterility” and “Reproductive Biomedicine Online”. He is a permanent reviewer, among others magazines such as: “Human Reproduction”, “Reproductive Biology and Endocrinology”.
Professor Carp graduated from the Charing Cross Hospital Medical School in London. After a few years of work, he moved to Israel and works today at Sheba Medical. After a few years of work, he moved to Israel and works today at Sheba Medical Center, Tel Hashomer and at Tel Aviv University as Professor of Gynecology and Obstetrics. His scientific interests include infertility, causes of habitual miscarriages and ectopic pregnancies. He published over 170 original works, 16 review articles and six books. He is invited for lectures around the world.
received his Biochemistry Sciences Degree in 2006 from the University of Valencia in Spain. He is the Clinical Embryologist at the IVF Unit at the Instituto Valenciano de Infertilidad (IVI) from 2008. The primary areas of his research are cryopreservation and metabolomics. He has published several articles on the cryopreservation field. At the same time, he was Product Manager of Kitazato-Dibimed from 2009 to 2014, working as advisor for Kitazato-Biopharma Company.
Degree in Medicine and Surgery from the University of Zaragoza, 1992-1998. Specialization in Gynecology and Obstetrics. MIR at the University General Hospital of Alicante, 1999-2003. Doctorate and Research Sufficiency Courses, University of Miguel Hernández. Alicante, 2001Master in Laparoscopic Surgery Hospital Clínic de Barcelona, 2005.Postgraduate in Business Management Pompeu Fabra University (UPF) Barcelona, 2009.Master in Research in Management Science at ESADE, Barcelona 2009-2011.Doctorate in Medicine and Surgery. University of Valencia. Project: Prospective and randomized study on the utility of CGH Arrays for the study of embryonic aneuploidies in severe male factor.
Professor of endocrinology and reproductive medicine. Coordinator of the APHP care network for ovarian cancer and high-risk breast cancer at the National Institute of Cancer in Paris. He works at the Department of Obstetrics, Gynecology and Reproductive Medicine at the University Hospital Tenon Assistance Publique Hoptaux de Paris (APHP), at the University of Pierre and Marie Curie in Paris. Her clinical practice includes endocrinology, reproductive medicine and endocrine tumors. Her current projects focus on cancer and fertility, pharmacology, hormone-dependent cancers, the environment and the health of women. He is a member of the European Endocrinological Society, a member of the board of the French Society of Endocrinology, a member of the board of the European Society of Gynecology, a member of the board of the French Society of Gynecology. He is the coordinator of the Paris academic program on the medical aspects of gynecology and infertility (“Medical aspects of gynaecology and infertility”). She is the author of 110 publications indexed in PubMed.
Practising gynaecologist and obstetrician at the CHU de Rouen Hospital, Rouen, France, where she has created with the surgeon Pr Horace Roman the first French official Expert Center for Endometriosis. She has held this position since September 2014 as a fertility doctor, before which she was based at the Centre Hospitalier du Belvédère in France.She has served on the organising committe of the national reproductive medicine congress held in Rouen in 2013 (FFER), and is an active member of professional societies including those of the Groupe d’Etude du Don d’Ovocytes (GEDO), the Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Rouendométriose. She also is a member of the scientific committee of Endofrance (Association française des patientes atteintes d’endométriose). She is highly implicated in the management of patients suffering from endometriosis, and has been working since 2013 on the creation of a national network of expert centers of endometriosis. Her recent publications concern this particular topic, as well as fertility management in case of endometriosis.Her speaking engagements include those at local and national congresses, most recently at the Congrès de la Société de Médecine de la Reproduction, Montpelliers (France) in May 2018, as well as at The Society of Endometriosis and Uterine Disorders, Florence (Italy) in April 2018.
Herjan J.T. Coelingh Bennink
Doctor, specialist in the field of gynecology and internal diseases. Specializations took place in Leiden and Utrecht, the Netherlands. In 1976 he specialized in the field of gynecology and obstetrics. From 1976 he was the head of the Department of Endocrinology of Reproduction at the University Hospital in Utrecht. In 1987 he became executive vice president at Organon in the Netherlands in the Women’s Health R & D program and developed drugs like Puregon and Antagon, Nuvaring, Implanon, Cerazette and Livial (tibolone) contraceptives. In the years 1997-2005 professor at the Danish-language Free University in Brussels. In 2001, he founded Pantarhei Bioscience (PRB). In 2014, he founded Pantarhei Oncology (PRO) aimed at developing drugs against reproductive organ tumors.
biologist with a PhD in evolutionary biology, is researcher and professor of Molecular and
Translational Endocrinology at the University of Modena and Reggio Emilia. Responsible of the research
team in basic and translational endocrinology, where he studies the endocrine regulation of human
reproduction, glycoprotein and sex steroid hormones and their receptors. Main scientific achievements
account for studies of gonadotropin-mediated signaling, GPCR heteromerization and allosteric modulation
of hormone-induced intracellular signals. He is tutoring four post-doc fellows, four PhD students and about
ten Master Degree students per year, which are actively involved in international research projects in
collaboration with research teams from France, UK, Poland, Germany and South Africa.
Director of Department of Obstetrics, Gynaecology and Reproductive Medicine, CHLN – Hospital de Santa Maria, Lisbon, Portugal Full Professor, Obstetrics and Gynaecology, Medical School, Universidade de Lisboa, Portugal
Diana Cocei is Physician in Obstetrics and Gynecology at Columna Medical Center
Bucharest – Romania, Senior Embryologist in the IVF Department.
Diana graduated the University of Medicine and Pharmacy “Carol Davila” Bucharest,
Faculty of General Medicine in 1995, took the residency exam in Obstetrics and Gynecology
in 1995, became Specialist Physician in 2000 and M.D. degree in 2008.
She joined the IVF Department in the Clinical Hospital of Obstetrics and Gynecology
„Prof. Dr. Panait Sarbu” Bucharest as an Embryologist and became Coordinator of Assisted
Human Reproduction Department in oct 2008.
In 2009 she became Senior Embryologist, passing the exam held in Amsterdam at
ESHRE Annual Meeting.
From april 2011 she has been working in IVF department at Columna Medical Center,
as Embryologist and Coordinator.
She is former President of AER(The Embryologists Association from Romania)
In 18 years of experience in assisted human reproduction she participated and lectured
at more than 50 national and international meetings and conferences.
Prof. Justin Clark
Professor T Justin Clark is a Consultant Gynaecologist at the Birmingham Women’s Hospital, an Honorary Professor at the University of Birmingham and president of the British Society for Gynaecological Endoscopy.
He is one of the leading UK experts endoscopic surgery and diagnostic and therapeutic interventions in benign gynaecology. He maintains close links with the University of Birmingham, both in research and teaching, where he-is academic achievements were recognized when he was made an Honorary Professor (2015-) and Director of the Birmingham Women’s Hospital Clinical Teaching Academy.
He was elected as the West Midlands Member of the Royal College of Obstetricians and Gynaecologists in (2007-2013) and is a President of the British Society for Gynaecological Endoscopy (2020-) and sits on the European Society of Gynecological Endoscopy Executive Board (2020-).
He was a scientific editor on the British Journal of Obstetrics & Gynaecology (2009 – 2020) and is now an Editorial Board Member (2020-). Justin was awarded a Silver National Clinical Excellence Award in 2016.
Fernando de Mora
Pharmacologist, Pedagogue, Doctor of Veterinary Medicine, Doctor philosophy in pharmacology, Universit at Autònoma de Barcelona, Cerdanyola, 1993. Master of Business Administration, University ofChicago, 1999.Focuses on human medicines. Compares their effectiveness andsecurity. Professional with 22 years of experience in biomedical research(immuno pharmacology – basic allergy and asthma) in position stechnical and project management with solid facilities academic education in business administration. Development Consultant medicines (R & D) in the field of pharmaceutical products and the biotechnology sector. Expertise on the market of biosimilars inEurope and Latin America. Mechanisms of allergies, biosimilars andimmunogenic biopharmaceuticals.
Michel De Vos
Michel De Vos, doctor of medical sciences, is a clinical professorre productive medicine and a medical co-director at the CenterReproductive Medicine in UZ Brussel-VUB.He studied medicine in Ghent, Belgium, graduated in 1997. He isa graduate of obstetrics and gynecology in Ghent, Leeds (United Kingdom)Kingdom) and in Brussels, and in 2006 he qualified as a gynecologist.He obtained a PhD in medicine at the University of Leeds. In 2006he joins the Center for Reproductive Medicine in UZ Brussel-VUB. Hismain interests concern egg maturation (IVM)oocytes and fertility. In cooperation with scientists fromThe Follicular Biology Laboratory is involved in the research program translational to optimize clinical and laboratory aspectshuman IVM.
Dominique de Ziegler
graduated from medical school in Geneva and subsequently returned to the US to undertake a research fellowship at Mt Sinai Hospital in New York (Erlio Gurpide) followed by Residency and Clinical Fellowship at the UCLA medical center in Los Angeles, California. At UCLA, he trained under JG Moore, Bill Dignam, and during the Fellowship Howard L Judd, David R Meldrum and R Jeffery Chang. In Paris and New York, he directed Research and Fellowship for Columbia Laboratories. There, he primarily worked on the development of the vaginal progesterone gel Crinone, unveiling the existence of direct vagina to uterus transport phenomenon, or first Uterine Pass Effect (FUPE). In Geneva, Switzerland: Starting in 2000, he was in Geneva where he directed the division of Reproductive Endocrinology and Infertility at the university hospital (HUG), later fused with the same at Lausanne (CHUV). Currently, at University Paris Descartes – Hôpital Cochin, Paris France: he heads the Division of Reproductive Endocrinology and Infertility at University Descartes – Hôpital Cochin in the dept of Obtetrics and Gynecology chaired by Charles Chapron. Together with Charles, he has exploited the unique model constituted by women affected by ovarian endometriosis for challenging the current views on ovarian reserve, ART out come and the fecundity of women.
Evanthia Diamanti-Kandarakis is Professor of Internal Medicine (Endocrinology and Metabolism) and Chairman of the Third Department of Medicine, Medical School, University of Athens (Greece). She received her MD from Medical School of Athens (Greece) and her PhD in Experimental Endocrinology on the effects of androgens in hypophysectomized rats from the same university. She did her training in internal medicine in England (1974–1980), and her training in endocrinology and metabolism in the USA (1980–1986). Her research interests have focused for the last 15 years on clinical, molecular and environmental aspects of metabolic and hormonal abnormalities in polycystic ovary syndrome. This work has generated more than 120 publications and more than 3500 citations. She has been invited by the international academic community as a speaker and has given more than 100 lectures in Europe, Asia, Africa, and North and South America.
Waljit Dhillo is Professor of Endocrinology & Metabolism and Consultant Endocrinologist at Imperial College London. He completed his medical training at St Bartholomew’s Hospital Medical School, University of London. During this time he completed an Intercalated BSc (First Class Honours) in Biochemistry funded by the Medical Research Council. Subsequently during his clinical training he completed a PhD as a Wellcome Trust Clinical Training Fellow at Imperial College. He was subsequently awarded 3 National Institute for Health Research (NIHR) personal Fellowships – Clinician Scientist Fellowship 2004-2009, Career Development Fellowship 2009-2015 and most recently a Research Professorship 2015-2020. He was appointed to a personal Chair at Imperial College in 2011.
Professor Olivier Donnez, M.D. Ph.D., is co-CEO and co-founder of the Institut du sein et de Chirurgie gynécologique d’Avignon (I.C.A.) He is actually gynecologic surgeon at the Polyclinique Urbain V, Avignon, France (ELSAN Group). He was the head of department of gynaecology and in vitro fertilization, CHU Dinant Godinne UCL Namur in Belgium from 2005 until 2015. He received his medical degree in 2000 and his PhD in 2013 from the Catholic University of Louvain (UCL). He is still involved in research projects in the “Institut de Recherche Expérimentale et Clinique”, GYNE pole, of the UCL. Olivier Donnez is member of the European Society of Gynaecological Endoscopy (ESGE), European society of Gynaecological Oncology (ESGO), American association of gynaecologic laparoscopist (AAGL), International society of fertility preservation (ISFP)He is member of the advisory board of the Society of Gynaecological Endoscopy (ESGE). He is reviewer for the European Journal of Obstertrics and Gynecology, PLOS One, and Gynecological surgery. He is a member of the editorial board of Fertility and Sterility.
Dr Panagiotis Drakopoulos MD, Msc is a specialist in the field of gynecology / fertility, working in the Center for Reproductive Medicine in the UZ Brussel in Belgium and at the University Hospital in Liege, Belgium. Isauthor of numerous peer-reviewed articles about the high index in endocrine magazines regarding reproduction. serves Reviewer in several journals in this field, including Human Reproduction, Human Reproduction update and Fertility & Sterility.His research focuses mainly on strategies aimed at improving the results of patients with a low prognosis after ovarian stimulation.
Prof Duleba is the Chief of the Division of Reproductive Endocrinology and Infertility and Professor of Obstetrics, Gynecology, and Reproductive Sciences at the UC San Diego. He is an expert in the regulation of ovarian function and the diagnosis and treatment of infertility, with a special interest in PCOS.
Francesca E. Duncan
is an Assistant Professor in the Department of Anatomy and Cell Biology at the University of Kansas Medical Center (KUMC). She has over 15 years of experience in reproductive biology and has trained with leaders in the field of gamete and ovarian biology, including Carmen J. Williams, MD, PhD and Richard M. Schultz, PhD at the University of Pennsylvania and Teresa K. Woodruff, PhD at Northwestern University. Her independent laboratory is focused on understanding the cellular mechanisms of how aging – both physiologic and iatrogenic – impacts reproductive potential at the levels of the gamete and ovary. Dr. Duncan is an active member of the Oncofertility Consortium spearheaded by Dr. Woodruff. Since 2009, she has co-authored >20 publications on fertility preservation-related topics with Dr. Woodruff. In addition, she and Dr. Woodruff co-authored the first chapter on Fertility Preservation in the revered medical textbook: Yen and Jaffe’s Reproductive Endocrinology. Dr. Duncan serves as the Basic Science Subgroup Leader of the Oncofertility Consortium’s National Physicians Cooperative. In addition, she is the Principal Investigator of a pilot project funded through the Center for Reproductive Health After Disease focused on radiation therapy and the extra-follicular ovarian microenvironment.
Mark Hans Emanuel
MD(with honours) PhD (University of Amsterdam) was trained at the Academic
Medical Center of the University of Amsterdam. Since 1992 he was working in the Spaarne Hospital
(University of Amsterdam) as a staff consultant gynaecologist and board certified trainer. Since 2017
he works in the University Medical Center in Utrecht (The Netherlands).
In 1998 he wrote his PhD-thesis entitled: Submucous Myomas and Abnormal Uterine Bleeding;
epidemiology, diagnosis and treatment. His special field of interest is diagnosis and treatment of the
uterine cavity (ultrasonography and hysteroscopy).
He is a specialist in advanced hysteroscopic surgery and he is directing an International Referral
Center for advanced hysteroscopic surgery and Asherman Syndrome. He is a former Board Member
of the Dutch Society of Obstetrics & Gynaecology (NVOG) and the International Society for
He was invited to join FIGO Menstrual Disorders Committee Meetings on fibroids.
He is visiting professor at the University of Ghent (Belgium).
He won several awards from The Society of Reproductive Surgeons, The American Association of
Gynecological Laparoscopists and The European Society of Gynecological Endoscopy. He was
awarded as Dutch Inventor of the Year for the development of Hysteroscopic Morcellation or Tissue
He holds patents related to CE Marked and FDA approved Hysteroscopic Morcellation (TruClear,
MyoSure), Gel instillation Sonohysterography and Hysterosalpingo Foam Sonography respectively
(ExEm Gel and Foam).
Reproductive Biologist, specialized in the analysis and cryopreservation of sperm and testicular tissue, as well as in the evaluation and preservation of male fertility. Working since 1995 in the field of Laboratory Seminology, as the andrology laboratory director of the largest sperm bank in Greece.
Graduated from the Department of Biology of the School of Sciences of the National and Kapodistrian University of Athens, in which she was admitted first among the candidates of her year.
Master’s degree (M.Phil) from the Medical School of the University of Nottingham in Great Britain, during which she as educated on the techniques of basic and functional semen parameters’ evaluation, as well as on the applications of sperm and testicular tissue cryopreservation.
Ph.D holder from the Department of Medicine of the Democritus University of Thrace and Research associate of the Postgraduate Studies Course entitled ‘Human Reproduction’, in which she participates since its commencement, with lectures and practical laboratory training workshops.
Certified by the European Society of Human Reproduction and Embryology (ESHRE) as a trainer for basic sperm analysis.
Part of her research studies is included in the 6th Edition of the WHO laboratory manual for the examination and processing of human semen (2021), constituting the first Greek contribution in the new world reference limits for basic semen parameters.
Roy G Farquharson
Dr. Roy G Farquharson was born and educated in Aberdeen, Scotland inGreat Britain.Specialized training was taken at Aberdeen MaternityHospital, National Hospital for Women, Auckland, NZ, pre-schoolhigher at the University Hospital in PoznanWales, Cardiff, where the master’s thesis on the subject was completedfetal endocrinology. He is currently the president of the European UnionAssociation of Human Reproduction and Embryology (ESHRE, 2017-2019).She is a co-editor of early pregnancy (Cambridge University Press, 2issue, 2017). He was an NHS consultant at Obstetrics and Ginekologia wLiverpool Women’s Hospital from 1986 to 2015 involved inRCOG and NICE guidelines, education and training projects.
Bart CJM Fauser
Bart Fauser is Professor of Reproductive Medicine at the University of Utrecht in The Netherlands and Chair of the Division of Woman & Baby (Departments of Reproductive Medicine & Gynecology, Obstetrics, Neonatology) at the University Medical Center in Utrecht (since 2004). He is a former Professor of Reproductive Endocrinology and Director of the Center of Reproductive Medicine at the Erasmus Medical Center in Rotterdam (1996-2003); Visiting Professor, University Southampton, UK (since 2010); Saal van Zwanenberg Professor, Center of Reproductive Medicine, Free University, Brussels (2003-2008); Visiting Professor, Stanford School of Medicine, Palo Alto, California (1993-1995); and Fulbright post-doctoral Scholar, University of California, San Diego, California (1987-1988). From 2001-2007, Professor Fauser was the Editor-in-Chief of ‘Human Reproduction Update.’ He has published around 300 PubMed papers (Hirsch factor 52). Professor Fauser serves on many international editorial boards and has been active in many international societies. His work has been widely covered in national and international news media. His major research interest is pathophysiology of human ovarian function.
Stephen FranksHe is Professor of Reproductive Endocrinology at Imperial College Faculty of Medicine (University of London) and Consultant Endocrinologist at St Mary’s and Hammersmith Hospitals, London. He has recently completed a term as Chairman of the Society for Endocrinology (UK). He has both clinic and laboratory based programmes of research in the field of normal and disordered follicular development, predominantly in the human ovary. He has a major interest in polycystic ovary syndrome (PCOS), which is not only the commonest cause of anovulatory infertility, but is also a major risk factor for development of type 2 diabetes. His research includes investigation of the mechanism(s) of anovulation, and of the characteristic metabolic abnormalities; it focuses particularly on the interaction between genetic and environmental factors in the aetiology of the syndrome.
is a specialist in Gynecology and Obstetrics, and has endorsed reproductive medicine since the late 1970s. He is currently Scientific Director of S.I.S.M.e.R. (Società Italiana di Studi di Medicina della Riproduzione), based in Bologna, Italy; Scientific Director of the IIARG network (International Institutes of Advanced Reproduction and Genetics) which brings together specialized centers located in various European countries. He is the former President of the Italian Reproduction Society and the European Society of Human Reproduction and Embryology (ESHRE). To date he is the coordinator of the ESHRE Task Force on Management of Fertility Units and the ESHRE Certification for Reproductive Endoscopic Surgeons.
Professor Reproductive medicine, Malmö at Lund University, Sweden. Focuses on Cancer and Oncology and on male reproductive function, fertility. His group is focusing on reproductive aspects of cancer and cancer treatment in young males. The group also studies the impact of cancer and cancer therapy on the health of the children of young male cancer survivors, by molecular studies on spermatozoa from cancer survivors, as well as by the use of national registries.
Georg Griesinger is a full professor at the Obstetrics and Gynecology Department at the University Clinic of Schleswig-Holstein, Lübeck, Germany. He completed an internship at the University of Vienna, where he worked on the research of trophoblast for his MA thesis at the Faculty of Obstetrics. Then he completed post-graduate studies at University College in London, where he obtained a master’s degree in prenatal genetics and fetal medicine. The subject of his doctoral dissertation concerned ovarian stimulation in in vitro fertilization using GnRH antagonists. His research interests include endocrinology of ovarian stimulation, epidemiological studies in in vitro fertilization and basic aspects of folliculogenesis and cryopreservation of ovarian tissue. He was the deputy editor of the journal “Human Reproduction” in 2008-2012 and the magazine “Fertility and Sterility” in 2010-2012. He is currently the editor of the section in “Reproductive Biomedicine Online.” He is also a member of the Gynecology and Fertility group in the Cochrane organization (CGF). Beginning in 2012, Georg Griesinger is a visiting professor at the International University of Dubrovnik in Croatia and a member of the infertility group at the World Health Organization. In addition, he has been a member of the Executive Committee of ESHRE since 2013.
Stine Gry Kristensen
She is a biologist with a PhD in reproductive biology from the University Hospital of Copenhagen. She has been cryopreserving ovarian tissue for fertility preservation since 2009 at the Laboratory of Reproductive Biology in Copenhagen. Her research has been focused on the very early stages of human folliculogenesis.
studied Computer Science and Economics in Hungary. After gaining master of science degree he moved to Finland. He accomplished his PhD programme at University of Turku. He specialized in Computer Science, especially mathematics, algorithm theory and data mining. In 2013 he got Docent in Bioinformatics at University of Turku. He now works as a Head of the Bioinformatics & Scientific Computing Core Facility, Campus Science Support Facilities (CSF), Vienna Biocenter, Vienna, Austria. He is now supervising Ph.D. and M.Sc. students. He is actively developing novel methods and tools for the analysis of high-throughput, especially microarray and next-generation sequencing data. He is leading a bioinformatics group that provides extensive high-throughput data analysis services for various microarray and next-generation sequencing applications, strong and wide experience in programming and script languages, database systems and statistical tools: JAVA, Perl, Python.
Juan García-Velasco, MD, PhD, is Director of IVI Madrid. He is also the Professor of Obstetrics and Gynaecology at Rey Juan Carlos University, Madrid, Spain, where he is Director of their Master’s Degree Programme in Human Reproduction. Professor García-Velasco graduated from University Medical School, Madrid, in 1990 and received his Obstetrics and Gynaecology certification from La Paz Hospital, Madrid, in 1995. He completed his PhD in Medicine from Autonoma University, Madrid, in 1995 and from 1997 to 1998 he studied at Yale University, New Haven, CT (USA), under a Reproductive Endocrinology and Infertility Fellowship.
His main research interests have been in Recurrent Implantation Failure and Endometriosis. He is the Principal Investigator of projects funded by the Ministry of Education and Ministry of Health, Spain, and has received awards from the Spanish Fertility Society, Spanish Society of Obstetrics and Gynaecology, and the European Society of Human Reproduction and Embryology. He has
published over 200 peer-reviewed articles as well as 30 book chapters on human reproduction, endometriosis and hypo- and hyper-ovarian stimulation response. He is the Co-Editor of Reproductive Biomedicine Online RBMO.
is a basic scientist and Research Director at the French National Institute of Health and Medical Research (INSERM) in Lille, France. His research is focused on neurodevelopmental events leading to the correct maturation and function of the mammalian reproductive axis. Among infertility disorders, his group is currently interested in understanding the neuroendocrine basis of polycystic ovary syndrome (PCOS).
Joyce Harper is Professor at the Institute for Women’s Health at University College London where she is Director of Education, Head of the Department of Reproductive Health and Director of the Centre for Human Reproduction. She has worked in the fields of fertility, genetics, reproductive health and women’s health for over 30 years. She is passionate about education and discussion of all aspects of women’s health. She is the mother of three sons born through IVF.
Fertility and Stem Cell Syndrome (G-FaST), Faculty of MedicineReproduction, Ghent University Hospital.He directs his research to infertile couples who can not be treated forcurrently available assisted reproduction technologies.These include (i) sterile pairs without gametes for which we want to createde novo genes from human embryonic stem cells; and (ii)couples who have experienced unsuccessful fertilization and puberty afterintra-pleated sperm injection (ICSI).
Dr. Hananel Holzer is currently the Director of two leading IVF centers in Israel. Dr. Holzer is the Former Medical Director of the McGill University Health Centre Reproductive Centre and the Reproductive Endocrinology and Infertility Division of McGill University. He is also involved in developing fertility related projects around the world mainly in Central Europe. His main interests are fertility preservation for cancer patients, in-vitro maturation of oocytes and a comprehensive team approach to infertility related issues.
Colin Michael Howles
For 36 years he worked in the field of reproductive endocrinology.He began his career in IVF in 1984, when he went to work inthe first IVF clinic in the world, Bourn Hall Clinic, Cambridge,straight fromProfessor Robert Edwards (Nobel laureate 2010 in the fieldphysiology or medicine) and Patrick Steptoe.Colin is currently based in Geneva, and in 2013 he founded the ARIES companyConsulting, which aims to improve the results of infertility treatment.ARIES Consulting Sarl,from June 2017, he provided consulting services for three European companiesbiotechnology, one of which (Finox is now part of the groupGedeon Richter) recently launched r-hFSH. He worked with the producerIVF laboratory equipment that introduced the system to the marketincubation changing game time, American and EU companiesbiotechnology, Venture Capital groups, pharmaceuticalscompanies in Europe, as well as directly at IVF clinics in Australia, USA,Japan, Great Britain, Italy, Switzerland and Vietnam.
received his MD and PhD at University of Helsinki, Finland, did postdoctoral training in USA, and has been on sabbatical leave in Germany, USA and Scotland. He held 1986-2002 the post of Professor and Chairman of Physiology at University of Turku, Finland. He moved in 2002 to UK to a Chair in Reproductive Endocrinology at Imperial College London. He has been the Chief Managing Editor of Mol Cell Endocrinol since 1999, has served in Editorial Boards of Endocrinology and Endocr Rev and is/has been the Editor or Editorial Board Member of several other scientific journals (e.g. Eur J Endocrinol, Clin Endocrinol, Hum Reprod Update, J Endocrinol, Mol Hum Reprod, Reproduction, Asian J Androl). His research interests include clinical and basic reproductive endocrinology, in particular the function of gonadotrophins, G-Protein coupled receptor signalling in reproduction and cancer, Physiology and pathophysiology of the hypothalamic-pituitary-gonadal axis, male contraception, endocrinology of ageing. He also has long-term interests in the development of male contraception, hormone-dependent cancer, and the endocrinology of ageing. He has authored about 600 peer-reviewed research articles. Ilpo Huhtaniemi is a member of Academy of Medical Sciences, Finnish Academy of Science and Letters, Endocrine Society (USA), Society for Endocrinology (UK), European Academy of Andrology, European Society of Endocrinology.
is a specialist in reproductive endocrinology, professor and clinical director of the Fertility Clinic at Odense University Hospital, Denmark. He trained at the Sahlgrenska University Hospital, Gothenburg, Sweden, where he also completed a speciality degree in obstetrics and gynaecology. His research interests include reproductive endocrinology, the function of gonadotrophins, sperm chromatin integrity in relation to assisted reproduction and gonadotrophin-releasing hormone (GnRH) antagonist co-treatment in ovarian stimulation. During recent years, his research has been focused on GnRHa triggering and prevention of ovarian hyperstimulation syndrome. He is a former board member of the Danish Fertility Society.
Anat Hershko Klement
MD completed her Obstetrics & Gynecology residency in 2010 and was later a postgraduate in reproductive endocrinology and infertility in Toronto. She is currently the head of the reproduction and IVF unit in Hadassah mount Scopus. Her special research interests are epidemiological aspects of ART and IVF pregnancy outcomes.
Professor Roy Homburg
MB.BS, FRCOG Professor Homburg is an obstetrician and gynaecologist who specialises in reproductive medicine. He has held posts as Professor of Obstetrics and Gynaecology at Tel Aviv University Medical School, as Professor of Reproductive Medicine at the Free University Medical Centre in Amsterdam, The Netherlands and, presently, as Professor of Reproductive Medicine at Queen Mary, University of London.Professor Homburg now consults in the UK, as Head of Research at the Homerton Fertility Centre, Homerton University Hospital in London and at the Hewitt Fertility Centre at the Liverpool Women’s Hospital. As a fertility specialist, Professor Homburg has a worldwide reputation having published more than 230 research articles and chapters in books and has written or edited seven books. He has been invited to lecture in all five continents at frequent intervals and has won prizes for his research at the British Fertility Society (twice), the ASRM, ESHRE and the Israel Fertility Society (3 times). He has served as an associate editor for Human Reproduction, for Human Reproduction Update and is presently the International Advisor for the Special Interest Group of Reproductive Endocrinology in ESHRE and Section Editor for Reproductive Biology and Endocrinology.Professor Homburg’s main interests and speciality are the treatment of infertility in general, polycystic ovary syndrome, ovulation induction, ovarian stimulation and IVF.
Dr. Rumana Islam graduated from the University of Nottingham in the United StatesUnited States 2006. Then she began training in the field ofobstetrics and gynecology in North West London works in suchunits like Chelsea and Westminster Hospital Queen Charlotte Hospitaland Hammersmith. It’s in IVF Hammersmith whereRumana started researching kisspeptina, in which she won the titledoctor (Res) diploma at Imperial College London, also publishedin the field of fertility behavior has now been appointedscholarship holder of subspecialism in reproductive medicine in hospitalsUniversity of Oxford.
a Professor of Stem Cell Science at the King’s College London, United Kingdom. The focus of his work is translational aspects of human reproduction and stem cell research.
University professor, he practices at the University Hospital (CHU) in Caen, France. Coordinator of the Center for Developmental Anomalies and Center of rare diseases of calcium and phosphorus metabolism. He is also professionally involved in the molecular genetics of cancers.
graduated from the Albert Szent-Györgyi School of Medicine in Szeged in 1994.
Following in the footsteps of his father and grandfather, he chose to become an obstetrician and
gynecologist. He completed his obstetrics and gynecology residency training at the Albert Einstein
School of Medicine in New York, USA. Upon finishing the residency training, he completed a
subspecialty training in reproductive endocrinology and infertility at the same institute (Albert
Einstein College of Medicine). He has received board certification in both obstetrics-gynecology
and reproductive endocrinology and infertility in the USA.
Soon after completing the fellowship subspeciality training he moved back to Hungary and
assumed a reproductive endocrinologist and infertility specialist position at the Kaali Institute in
Budapest. In 2008 he was promoted to become the medical director of the clinic.
During his career he considered clinical research to be as important as clinical work. In 2005 he
earned a PhD degree from the Medical School of Pécs for his work on studying the impact of
diabetes and insulin on GnRH neuron activity. Throughout his scientific career, he has published
more than 55 peer-reviewed articles in Hungarian and leading international scientific journals, has
presented at over 70 Hungarian and international scientific meetings and has published 12 book
chapters. He is the co-author of the first Hungarian textbook on diagnosis and treatment of
infertility. He has been publishing regularly on WebMD over the past 20 years and has been on its
Editorial Board since 2002.
In 2011 he was appointed to become a member of the Hungarian Committee for Human
Reproduction and he has represented Hungary in the European Society for Human Reproduction
and Embryology (ESHRE) for eight years.
Dr Kovács speaks English and Hungarian. He enjoys playing sports in his free time. He used to be a
competitive tennis player, but he now enjoys it as a hobby with his family, as all four of his sons are
also tennis players.
Borut Kovačič began his career in 1988, when the IVF laboratory of the Department of Reproductive Medicine and Gynecology of Endocrinology at the University Medical Center in Maribor was opened. He is currently the head of this laboratory and participates in many research projects. In 1999 he obtained a PhD at the University of Ljubljana, Slovenia. He is currently an associate professor of biological sciences at this university. His bibliography includes over 100 scientific articles and book chapters. Borut Kovačič is an active member of ESHRE. Coordinates the Embryology Certification Committee and is a member of the Executive Committee from 2015.
Barbara Lawrenz works as a specialist in in vitro fertilization at the IVI Middle East Fertility Clinic in Abu Dhabi, UAE. Previously, she was the head of the in vitro fertilization unit at the University of Tübingen, Germany. It focuses mainly on the preservation of fertility before the initiation of cytotoxic treatment in women with malignant diseases and on pregnancy after breast cancer. She is the author and co-author of 30 peer-reviewed scientific articles and numerous articles in German magazines. For her post-doctoral thesis on preservation of fertility before cytotoxic treatment in young girls, adolescents and women in the pre-menopausal period, she was nominated as a lecturer (“Privatdozentin”) and obtained a didactic license of the University of Tübingen in the field of gynecology and obstetrics.
She practices at the State Scientific Laboratory in the field of agrobiotechnology at the Chinese University of Agriculture in Beijing.
Head of In Vitro Laboratories and member of the research team INVICTA Fertility Clinics. Embryologist with many years of experience. She has the ESHRE Senior Clinical Embryologist certificate. Co-author of scientific projects on proprietary preimplantation diagnosis for rare diseases and the effectiveness of embryological procedures in the infertility treatment. As a precursor in the country, she implemented, among others methods of cryopreservation of egg cells and ovarian tissue, FAMSI procedures and sperm separation. A member of many Polish and international scientific societies (PTGC, PTDL, ESHRE, ASRM, PGDIS).
Dr Kersti Lundin received a PhD in zoophysiology at the University of Gothenburg in Sweden in 1991. She then began working as an embryologist and researcher in the reproductive medicine unit at the Sahlgrenska hospital in Gothenburg, where in 1997 she became the director of the reproductive medicine laboratory in 2004. associate professor. Dr. Lundin has published many articles and chapters in international and national scientific journals and books. She participated in the appointment and running of both the Swedish and Nordic Association of IVF Laboratories. Her main interests are basic and clinical embryology, including the development of embryos and cryopreservation. She was a member of ESHRE ExCo (2005-2009), embryological board SIG (2005 – 2013) and embryological certification board (2007-2015).
Dr Stefania Lymperi received her BSc in Biology from the Aristotle University of Thessaloniki, Greece (AUTH). She received her MSc i n Human Molecular Genetics and her PhD in Stem Cell Biology from Imperial College London, supported by the State Scholarships Foundation of Greece. Stefania then worked as a postdoctoral fellow at Harvard Medical School and Massachusetts General Hospital in Boston, USA. She is currently directing her private Andrology Laboratory in Thessaloniki and in paralle is teaching at the master course of the Biology School of AUTH and is a staff of the Training Center of the European Academy of Andrology in Thessaloniki.
Dr Phill Matson has extensive experience and expertise in reproductive technology with a particular focus on andrology, endocrinology, and procedures using patient and donor gametes and embryos. He has been the Scientific Director in fertility clinics both in the UK and Australia, and is currently the Principal Scientist at Fertility North here in Western Australia. While in the UK, he became the first Consultant Clinical Scientist with full IVF responsibility in the National Health Service, being formally equivalent to a medical specialist. In addition to his work as a clinical scientist, he helped establish the Reproductive Biology Unit at Perth Zoo.Phill was the inaugural Chair of the Association of Clinical Embryologists (ACE) and was recently accepted as a Fellow of the Royal College of Pathology in the Specialty of Clinical Embryology. In the UK he was instrumental in establishing the world’s first External Quality Assurance Program for andrology and later helped create the External Quality Assurance Schemes for Reproductive Medicine in Australia. He has served on the committees of various professional bodies including the British Andrology Society, British Fertility Society, Fertility Society of Australia, Scientists in Reproductive Technology (SIRT), the Endocrine and Reproductive Biology Society of WA and the NHMRC Embryo Research Licensing Committee. He is currently the Chair of the Reproductive Technology Accreditation Committee (RTAC).
Jean Marc Mayenga
Doctor Jean Marc Mayenga – a gynecologist and obstetrician, specialist in the field of reproductive medicine and surgery. He practices in the Department of Gynecology, Obstetrics and Reproduction. Man at the Hospital Hospitalier des Quatre Villes Hospital in Saint-Cloud, France.He graduated in medicine at the Faculty of Medicine of Liège (Belgium) in 1985. His main interests are: ministerial support for assisted reproduction techniques, polycystic ovary syndrome, endometriosis, early pregnancy, surgery, ethics.Dr Marenga cooperates with GIERAF (Groupement Interafricain d’Etudes et de Recherche Appliquée à la Fertilité). He is a mentor of the CAM-TAM project initiated by the Sanofi Espoir Foundation to reduce maternal and fetal mortality in Tanzania. He actively participated in the 3-year cooperation program initiated by prof. Szamatowicz and Jean Cohen between France and Poland in the field of reproductive medicine. Dr. Marenga taught at the Midwifery School of C.M.C Foch (Suresnes) in 1997-2007, lecturing at the master’s degree in biology at the Paris University of Descartes.
Prof Enda Mcveigh is holding the postion of Associate Professor and Consultant and Sub-Specialist in Reproductive Medicine and Surgery at the The Nuffield Department of Women’s & Reproductive Health, University of Oxford, UK.He was one of the Foundering Partners of an IVF clinic network (Reproductive Partnership) which is now the largest in the UK. Working with Stephen Kennedy, he facilitated the development of the now very successful MSC course in Reproductive Medicine which is closely linked to the IVF facility. Prof Mcveigh’s research has been mostly based in Reproductive Medicine and Endometriosis, as well as ovarian tissue cryopreservation for pre-pubertal and adolescent girls and also supporting the Endometriosis research activity.
Professor of reproductive endocrinology since 2005 at the Faculty of Sciences oAnimals at the Hebrew University in Jerusalem at Rehovot inIsrael. Her research in the field of reproductive endocrinology aremainly focused on the corpus luteum.Ph.D. – Weizmann Scientific Institute, Rehovot Israel-1987M.Sc. – The Weizmann Institute of Science, Rehovot Israel -1978B.Sc. – Ilan University Bar, Kiryat Ono, Israel-1975
Senior clinical embryologist in obstetrics and gynecology hospital “Dr. Shterev “. She obtained a PhD in biological sciences in the field of embryology in 2010 at the Medical University of Sofia. He works as a biologist – embryologist at SAGBAL “Dr. Shterev “- Medical Center” Reproductive health “- in the in vitro fertilization department (from March 2000). He is currently the head of the in vitro fertilization and androgenology department at SAGBAL “Dr. Shterev “(since 2010). Her professional interests: cryopreservation of preimplant gametes and embryos, IVF, preimplantation diagnosis, epigenetics. Since 2011, he is the younger deputy at SIG Reproductive Genetics at ESHRE and a member of the National Representative Committee of Bulgaria (CNR) at ESHRE.
Professor of biochemistry and molecular biology at the Faculty of Medicine at the Paris-Sud University in Paris. Her interests focus on molecular and cellular mechanisms in reproductive and thyroid endocrinology, nuclear receptors, membrane receptors, infertility genetics, and primary ovarian failure. Author of over 100 publications. Her main work is published in Science, Nature, PNAS, New England Journal of Medicine, and JAMA. Over 6,000 citations.
Laure C. Morin-Papunen
Laure Morin-Papunen works as an associate professor and head of the Department of In Vitro Fertilization and Gynecological Endocrinology at the University Hospital in Oulu, Finland. She is the lead researcher in the polycystic ovary syndrome research group at Northern Finnish Cohorts 86 and 66. She was the project manager and researcher initiating the Finnish, multicenter RC study on the impact of metformin treatment on female PCOS infertility. The main goal of her current research is the long-term effects of polycystic ovary syndrome on fertility, cardiovascular risk factors and the risk of glucose metabolism disorders.
Juho-Antti Mäkelä, PhD, is a research fellow and a university teacher at University of Turku, Turku, Finland. Dr Mäkelä has performed research on different aspects of spermatogenesis and male germ cell development. During recent years his primary research focus has been on mechanisms underlying germline stem cell maintenance and differentiation.
Monica Muratori is an assistant at the Faculty of Experimental, Clinical and Biomedical Sciences at the University of Florence in Italy. The latest directions of her research include: sperm DNA fragmentation, sperm protein modifications. She is the author of 60 articles in international scientific journals and 11 chapters in national and international books. He is the deputy editor of the journal Human Reproduction, a member of the editorial team of the journal Andrology (from January 2016).
Raoul Orvieto is a full professor at the Faculty of Health Sciences at the University of Ben-Gurion and director of the Infertility and In Vitro Fertilization Department at the Sheba Medical Center in Israel. Specializes in fertility, obstetrics and gynecology. He is the author and co-author of over 150 publications in domestic and foreign magazines. His scientific interests include various aspects of controlled ovarian hyperstimulation (COH), the role of GnRH analogs, specifically GnRH agonists as compared to antagonists in COH in in vitro fertilization and various aspects of ovarian hyperstimulation syndrome (OHSS): pathophysiology, prediction, prevention and its relationship to inflammatory reaction.
Professor Allan Pacey is a senior lecturer and head of the Department of Andrology. He was the chairman of the British Fertility Society and also chaired the Steering Group of the British National Quality Assurance System in the field of Andrology (the body supervising the quality of diagnostic semen tests). He is an experienced researcher with over 100 publications on male infertility. He works in the editorial offices of “Human Fertility”, “Reproduction” and “Fertility and Sterility”.
Antti Perheentupa is an associate professor specializing in reproductive medicine. His research interests include male fertility and infertility treatment in men. For over 10 years, he conducted a translational research project on endometriosis. Since 2007, Professor Perheentupa has been responsible for specialist trainings in the field of reproductive medicine.
Associate professor Dr. Terhi Piltonen, OBGYN and PI. She practices at the Reproductive Endocrinology and IVF Unit, Department of Ob-Gyn Oulu University Hospital, Oulu, FINLAND. The main scientific interest of Dr. Piltonen is on the lifelong health in PCOS; hyperandrogenism, mental and metabolic health issues. Lately, her research has also focused on early onset of the syndrome. The research team has several national and international collaborators in Europe, USA, Australia and Russia. Dr. Piltonen is active in publishing as well as lecturing in both national and international meetings.
Anja Pinborg is a medical doctor and expert in reproductive medicine and clinical professor at Rigshospitalet, University of Copenhagen, Denmark. She has published 130 original papers and authored seven book-chapters with an h-index of 34. She is executive committee member of ESHRE and is member of the International Committee of Medical Journal Editors (Vancouver group) and she was president for the Nordic Fertility Society (2011-2015). She is editor in chief for Danish Medical Journal (DMJ) and section editor for RBMOnline. Her main research areas are reproductive epidemiology including safety and quality aspects of ART with focus on ART children and clinical trials on optimizing ART and minimizing risks.
Nikolaos P. Polyzos
obtained his MD (2003) and PhD (2010) degrees in the University of Ioannina in Greece. He completed his specialty training in obstetrics and gynaecology in the University Hospital of Larissa in Greece. He joined the Center for Reproductive Medicine Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Belgium, in 2011, where in 2013 he obtained his second PhD degree in biomedical sciences and works as a gynaecologist visiting fellow. Currently he is a professor at Aarhus University, Denmark since March 2015 and in the Center for Reproductive Medicine at Vrije Universiteit Brussel since October 2015. He is a specialist in reproductive endocrinology and assisted reproductive technology. Dr Polyzos has served as reviewer for 15 journals, as associate editor for one journal and as editorial consultant for the Physician’s Information and Education Resource of the American College of Physicians. He is an author of over 190 publications; a member of ESHRE.
Margus Punab is Associate Professor in Andrology of University of Tartu, Institute of Clinical Medicine; Director of EAA Andrology Center of Tartu University Hospital; member of Academic Advisory Board of the President of the Republic
head of the Laboratoire de Biologie de la Reproduction – CECOS, Rouen, France specialized lab in Gametogenesis and gamete quality. Her group’s major interests are in Biological and technological quality of male gamete, Immature testicular tissue cryopreservation procedure, • In vitro spermatogenesis, • In vivo spermatogenesis after grafting (human and mice), • Predictive factor of human male gamete quality within the context of severe spermatogenesis impairment, • Endometriosis and ovarian functions
Kenny A. Rodriguez- Wallberg
Dr. Kenny A. Rodriguez Wallberg completed her medical education and her residency in obstetrics and gynecology in her home country, Colombia. As specialist, Dr Rodriguez-Wallberg was then awarded a fellowship from the Groupement Français de Gynécologie de l’Enfant et de l’Adolescence and completed her training in Pediatric Gynecology at Hôpital Necker Enfant Malades in Paris, as well as in Reproductive Endocrinology, Infertility and Assisted Reproduction at Cochin-Baudelocque. In 2005 she earned her PhD degree at Uppsala University in Sweden and since 2007, she is a Senior Consultant in Reproductive Medicine at Karolinska Hospital in Stockholm and Head of the Program for Fertility Preservation. Dr Rodriguez-Wallberg is currently sharing her clinical work with both clinical and translational research, supported by the Clinical Investigator’s grant from Stockholm county council, the Swedish Childhood Cancer Foundation, Radiumhemmets Research Fonds and Karolinska Institutet. Since 2013, Dr Rodriguez-Wallberg is Associate Professor at Karolinska Institutet and in January 2017 she was promoted to the position of University Lecturer in Reproductive Oncology at the Department of Oncology-Pathology of Karolinska Institutet.
Albert Salas-Huetos obtained his degree in Biology in 2009 at the Universitat de Girona (UdG), his MSc in Cell Biology in 2010 at the Universitat Autònoma de Barcelona (UAB), and his Ph.D. in Male Infertility in 2016 at the same University (UAB). He joined the Genetics of Male Fertility group (Department of Cell Biology, Physiology and Immunology -UAB-) and Human Nutrition Unit (Department of Biochemistry and Biotechnology -Universitat Rovira i Virgili; URV-) in 2016 as a Post-doctoral Fellowship. He had three-month Post-doctoral stay (September-November 2017) in the Universidad de Guadalajara in Mexico (UdeG). Nowadays, he is a Post-doctoral Fellowship at the University of Utah (The U) with Prof. Douglas T Carrell. His research has been mainly focused on male infertility genetics and nutrition and has been specialized in sperm miRNAs, molecular biology, Randomized Clinical Trials (RCT), systematic reviews, meta-analyses and applied statistics. Dr. Salas-Huetos is an inveterate traveler and has been to meetings and given invited lectures in Belgium, Canada, England, Mexico, USA, and Spain.
Maria de Los Santos
Dr. Maria J. de los Santos started her career in 1991 in the IVF laboratory of IVI Valencia. She received her Ph.D. in Biology from University of Valencia in 1996, and from 1996-1999 she carried out her postdoctoral fellowship in Reproductive Immunology at Fearing Research Laboratory at Harvard Medical School, under the supervision of Dr. Deborah Anderson and Dr. Joseph Hill. She also worked as clinical embryologist at the Brigham and Women ́s Hospital under the direction of Dr. Catherine Racowsky.
Xavier Santamaria Costa
Xavier Santa María Costa graduated in medical studies in 2003. In 2008 he graduated from the specialization in obstetrics and gynecology. He defended his doctoral thesis at the Autonomous University of Barcelona in 2013. While preparing his doctoral thesis, he obtained a postgraduate scholarship at the Department of Reproductive and Infertility Endocrinology at the Yale University (2008-2010). He also completed advanced training in gynecology at the Universitätklinikun München Grosshadern in Germany, in the field of laparoscopic surgery under the supervision of Professor Querleu at the Klaudiusz Regaud Institute – Toulouse (France) and at the Marine Biological Laboratory – Woods Hole (USA). He works as a specialist in obstetrics and gynecology in the field of reproductive medicine in the IVI clinic in Barcelona. He is currently the director of the Asherman project at iGenomix. His research interests are currently focused on the study of Asherman syndrome in iGenomix. In addition, he conducts research projects on endometriosis at the Vall d’Hebron Research Institute (VHIR). He is a member of ESHRE and the Spanish Society of Fertility (SEF). He is the main author of 10 articles in international journals and 8 chapters in books. He was invited as a lecturer at over 30 international conferences.
He graduated from obstetrics and gynecology at the Faculty of Medicine of the Parisian University of Descartes (Université Paris Descartes) in 2010, where he defended his doctorate in basic science in 2013. In 2014 in Paris he obtained the title of associate professor. He directs the surgery unit at the faculty headed by prof. Charles Chapron at the University Hospital in Cochin in Paris. His main research activities are as follows: basic research on the molecular immunological and inflammatory basis of endometriosis and infertility associated with endometriosis, clinical trials on the assessment and supervision (medical and / or surgical) of endometriosis and infertility associated with endometriosis, clinical research on gynecological surgery and assisted techniques reproduction in infertility. He is the author and co-author of about 60 original articles in peer-reviewed scientific journals.
Dr. Daniel S. Seidman is the director of the research unit and a physician in the IVF laboratory in the Department of Obstetrics and Gynecology at Sheba Medical Center, Tel-Hashomer, Tel-Aviv. He is also an adjunct at the Sackler School of Medicine, University of Tel-Aviv. He manages the Israeli Society of Contraception and Sexual Health.
Manuela Simoni in 1982-1990 worked as an endocrinologist at the Department of Endocrinology at the University of Modena, Italy, then as a molecular endocrinologist at the Institute of Reproductive Medicine at the University of Münster in Germany, where in 1998-2008 she held the position of professor of endocrinology and molecular biology of reproduction. Current positions: full professor and head of the Department of Endocrinology at the University of Modena and Reggio Emilia, director of the Clinical Department of Endocrinology at NOCSAE Hospital, director of the School of Specialization in Endocrinology, vice director of the Department of Biomedical, Metabolic and Neurological Sciences and director of the Center for Genetic Research at the University of Modena and Reggio Emilia. Her research interests include the action of gonadotropins and androgens, testicular function, male sterility genetics, endocrinology and reproductive pathophysiology. He is a member of several societies, including the European Academy of Andrology (EAA) and the European Endocrinological Society (ESE, acting as secretary). She works in editorial teams of several magazines in the field of endocrinology and reproduction.
Samuel Santos-Ribeiro obtained his medical degree in 2007 from Nova Medical School (Lisbon), concluding his training in Obstetrics/Gynaecology at Hospital Santa Maria (Lisbon) in 2015.
In 2013, he also initiated a Clinical Scholars Research Training (Harvard Medical School) and a research programme at Universitair Ziekenhuis Brussel (Brussels) with his Ph.D. thesis focusing primarily on the optimisation of endometrial receptivit.
Prof Johan Smitz MD PhD is based at the Centre for Reproductive Medicine (CRG) at the Free University Brussels (VUB), Belgium. He graduated as M.D. in 1980 and obtained his specialty in Clinical Pathology/Biochemistry/ Radio-Isotopes in 1986. He sub-specialised in Reproductive Medicine and got his PhD in 1993. From 1986 onwards he has been the head of the Endocrine Laboratory of the University Hospital. He became Professor of Endocrine Physiology and Reproductive Medicine in 1997 at VUB and founded the Follicle Biology Research Laboratory (FOBI). His main research activities are directed towards the implementation of basic techniques related to oocyte biology from the research laboratory into the clinical activities. Prof Johan Smitz is co-founder of two spin-off biotech conpanies ‘Fertiga’ and ‘Lavima Fertility’, a Spin-off company from the Free University Brussels (VUB) who target innovative technologies for the IVF laboratory.
Simpson, Joe Leigh
Joe Leigh Simpson, M.D., FACOG, FACMG, FRCOG, received his undergraduate and medical education at Duke University (M.D., 1968) and post graduate training at Cornell University Medical College (New York City). Academic positions have included: Professor at Northwestern University (1975-1986), Professor and Chairman of Obstetrics and Gynecology at University of Tennessee Memphis (1986-1994), Professor and Chairman of Obstetrics and Gynecology at Baylor College of Medicine (1994-2006), and Professor and Founding Executive Associate Dean for Academic Affairs at Florida International University, College of Medicine (2007-2011). He served as Senior Vice President for Research and Global programs, March of Dimes, (MOD) (2012-2018). He remained Professor of Human and Molecular Genetics/ Professor of Obstetrics and Gynecology at Florida International University throughout time at March of Dimes.
During the time he was on leave of absence from FIU, Dr. Simpson oversaw the MOD programs for conference support and individual investigator proposals. He developed a $60M program involving six prematurity research centers dedicated to discovering the causes of labor and, hence, preterm labor. Each center was chosen for its prowess in a given domain of discovery research and its ability to pursue collaborative investigations with other centers. Major discoveries have been made in genes associated with preterm birth, microbiome, fetal gene expression patterns during gestation, gene regulation and uterine pace-marker functions.
Dr. Simpson has contributed to many aspects of reproductive genetics, prenatal genetic diagnosis and birth defects. He is certified in Medical Genetics as well as in Obstetrics and Gynecology. He has written over 800 articles and chapters. His major books include seven editions as co-editor of Obstetrics: Normal and Problem Pregnancies and three editions for Genetics in Obstetrics and Gynecology. He has received research funding from NICHD, March of Dimes, USAID, and the Department of Defense.
Dr. Simpson has served in leadership roles for numerous grant review panels, prestigious national and international committees and many professional organizations. He has been President of the American Society for Reproductive Medicine, International Society of Prenatal Diagnosis, and Society for Gynecologic Investigation, American College of Medical Genetics, and Preimplantation Genetic Diagnosis International Society. He has been a member of the National Academy of Medicine, U.S. National Academy of Sciences since 1994.
He is active in many global initiations, especially in organizations in official relations with World Health Organization. As immediate Past President of the International Federation of Fertility Societies (IFFS), Dr. Simpson is Chair of the Scientific Committee for the 23rd IFFS World Congress (Shanghai, April 11-14, 2019)
Dr Tommy Tang is a consultant in the field of gynecology and a specialist in infertility at the Regional Center of Fertility at the Belfast Hospitals Trust. He completed training in the Yorkshire region and post-graduate studies at the University of Leeds, specializing in the use of insulin sensitizers in women with PCOS. His special interests are: reproductive endoscopy, endometriosis, recurrent miscarriages and ovulation disorders. Currently, he is an editor cooperating in “The Obstetrician and Gynaecologist” and in “Human Fertility”.
Received MD degree at the University of Oulu in 1980, completed PhD thesis work in 1982 and the residency in obstetrics and gynaecology 1988, and in reproductive medicine 1991 in the same institute. Special competence in andrology 2003. He has been a postdoctoral fellow (NIH) at the University of California San Francisco 1984-1985 and a visiting scientist at Stanford University 1991-1993.At present he is Professor and Chairman of the Department of Obstetrics and Gynaecology, Oulu University Hospital, Finland.He has been a member of ESHRE Executive Board and Financial Committee 2001-2005, and Reproductive Endocrinology Interest Group since 2001. He has been president of the Finnish Gynaecological Association and the Finnish Endocrine Society and served as member of ASRM International Affairs Committee and NFOG Executive Committee, and as assistant secretary and treasurer of IFFS. His clinical activities are focused on endocrinology, infertility and andrology. His research interests in the clinic are PCOS, insulin resistance, gonadotropin receptor mutations and infertility. In the basic research the main topics are the regulation of ovarian and testicular endocrine function, ovarian apoptosis and genetic causes of female infertility.
Fertility Specialist, Specialist in Obstetrics and Gynecology and Reproductive Medicine. Chief of Development of Ovumia-Fertinova clinic and co-founder of AVA Clinic in Lisbon, PorugalDr Candido Tomás was born in Portugal and studied Medicine at the University of Lisbon. He completed his specialisation in Obstetrics and Gynaecology at the University of Oulu, Finland in 1995 and finished his training in Reproductive Medicine in 2005. He completed his Ph.D. thesis in 1994. Candido Tomás started working with infertility patients in the University Hospital in Oulu since 1995, and has been continuously working as a fertility specialist and developing the management of AVA Clinic, Fertinova and presently in Ovumia-Fertinova, Tampere, Finland. He is one of the founders of AVA Clinic in Lisbon, Portugal and has been its first Clinical Director. He was involved in the initial articles of single embryo transfer and has developed a computer software system – BABE, which is in use in several infertility clinics in Finland and elsewhere.
Jorma Toppari is a professor of physiology at the University of Turku and the main physician of Pediatric Endocrinology at the University Hospital in Turku, Finland. He is also an adjunct professor at the Department of Growth and Reproduction at the University of Copenhagen, Denmark. He worked as the editor-in-chief of the International Journal of Andrology in 2001-2009 and in the editorial teams of several endocrinological journals, including currently in Endocrinology and Journal of Clinical Endocrinology and Metabolism. Former president of the European Academy of Andrology. Over the past 20 years, he has made a significant contribution to research on endocrine disorders. He is the author of about 300 articles in the field of endocrinology.
Fulco van der Veen
Fulco van der Veen is professor of reproductive medicine since 1997 at the University of Amsterdam. His research interests include evaluation studies in the field of predictive models in the field of reproductive medicine, preimplantation screening, ectopic pregnancy, male infertility, polycystic ovary syndrome, fertility preservation and translational research on human sperm stem cells. He is the author and co-author of over 400 publications, including the best magazines such as Nature Genetics, NEJM, JAMA and Lancet.
Michel De Vos
Michel De Vos, MD, PhD, has worked as a gynaecologist since 2006 and currently is a senior medical director at the Centre for Reproductive Medicine at Universitair Ziekenhuis Brussel, Belgium and an associate professor in reproductive medicine at
Vrije Universiteit Brussel. He studied medicine in Ghent, Belgium, and holds a PhD in medicine from the University of Leeds, UK. In 2011, he was recognised as a subspecialist in reproductive medicine and surgery by ESHRE and the European Board and College
of Obstetrics and Gynaecology (EBCOG). Michel has a keen interest in reproductive endocrinology, in vitro maturation of
oocytes and fertility preservation. He is a principle investigator of the FOTO (Freezing Ovarian Tissue and Oocytes) consortium, encompassing oncofertility research projects at three universities in Brussels: Vrije Universiteit Brussel (VUB), Université Libre de Bruxelles (ULB) and Université Catholique de Louvain (UCL) and he is a founding member of the Belgian Fertility Education Initiative (BFEI).
She was born in Palermo, Sicily, in January 1984. She received her M.D. Degree from the University of Palermo, School of Medicine, in June 2008. In June 2009 she started her residency program at Magna Graecia University of Catanzaro, Italy, where she obtained her Master Degree on July 2014. Since 2011 she is working in a clinical and scientific collaboration and Training program, particularly focused on fertility preservation techniques in patients with malignant and benign gynecological diseases at the GENERA A.R.T. Centers sited in Naples and Rome. During her residency, Dr. Venturella also improved her abilities in breast cancer diagnosis and treatment, attending the Breast Unit of Ospedale Pugliese Ciaccio of Catanzaro. On December 2016 has completed her PhD course at the Magna Graecia University, entitled: “Molecular oncology and translational innovative medical and surgical technologies for fertility preservation”.
Christine Wyns is the Head of the Cliniques universitaires Saint-Luc’s Gynaecology and Andrology Department, Medical director of the Reproductive Tissue and Cell Bank and serves as a Professor at Université catholique de Louvain (UCL). Professor Wyns specialises in female and male infertility problems. Her key areas of scientific interest include fertility preservation (cryopreservation).
did her PhD at the University Medical Center Utrecht in The Netherlands. She worked at Kendle International (1995-2000) as project manager and at Organon (2001-2006) as a clinical research scientist. In 2007, she started to work at Pantarhei Bioscience (PRB), the Netherlands. Since 2014, she also works at the daughter company Pantarhei Oncology (PRO), where she holds the position of COO. Her expertise and research interests are: Women’s Health (WH), immunology and oncology.